Journals / Turkish Journal of Clinics and Laboratory / 2024 / Cilt: 15 Sayı: 4

Myelodysplastic Syndrome and Artificial Intelligence

Myelodisplastik Sendrom ve Yapay Zeka

Fatma Yılmaz(Ankara Etlik City Hospital Department of Hematology)0000-0001-6112-3950
Pages
680–680
Publication Date
2024-12-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Studies with as many patients as possible are needed on this subject.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In the artificial intelligence that will be used in the diagnosis of MDS, the accuracy rate will increase if the database includes all the factors that are effective in the diagnosis and risk classification as much as possible.
📊
Key Findings & Data:Artificial intelligence applications that will be implemented using a database that includes as many factors as possible can guide the clinician in the diagnosis of MDS and even in individual treatment choices.
💡
Conclusion & Impact:Studies with as many patients as possible are needed on this subject.
🔬Design:Editöre Mektup
📍Scope:Comprehensive Sample
⚙️Variables:myelodisplastik sendrom · yapay zeka · myelodisplastic syndrom

Abstract

In the artificial intelligence that will be used in the diagnosis of MDS, the accuracy rate will increase if the database includes all the factors that are effective in the diagnosis and risk classification as much as possible. Artificial intelligence applications that will be implemented using a database that includes as many factors as possible can guide the clinician in the diagnosis of MDS and even in individual treatment choices. Studies with as many patients as possible are needed on this subject.

Özet

MDS tanısında kullanılacak olan yapay zekada veri tabanının tanıda ve risk sınıflamasında etkili tüm faktörleri olabildiğince içermesi doğruluk oranını yükselecektir. Olabildiğince çok faktörü barındıran veri tabanı kullanılarak uygulanacak olan yapay zeka uygulamaları MDS tanısında ve hatta bireysel tedavi seçimlerinde klinisyene yol gösterici olabilir. Bu konu ile ilgili hasta sayısının olabildiğince çok olduğu çalışmalara ihtiyaç vardır.

🔖

Cite This Article

Yılmaz, F. (2024). Myelodysplastic Syndrome and Artificial Intelligence. Turkish Journal of Clinics and Laboratory, Cilt: 15 Sayı: 4, 680–680. https://doi.org/10.18663/tjcl.1577122

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Karel D, Valburg C, Woddor N, Nava VE, Aggarwal A. Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape. Curr Oncol. 2024;31:1971-93.
  2. Sabile JM, Kaempf A, Tomic K, Manu GP, Swords R, Migdady Y. A retrospective validation of the IPSS-M molecular score in primary and therapy-related myelodysplastic syndromes (MDS). Leuk Lymphoma. 2023;64:1689-94.
  3. Elshoeibi AM, Badr A, Elsayed B, Metwally O, Elshoeibi R, Elhadary MR, et al. Integrating AI and ML in Myelodysplastic Syndrome Diagnosis: State-of-the-Art and Future Prospects. Cancers. 2023;16: 65.